C
Cognition Therapeutics D
D
CGTX
2.42500
USD
-0.05
(-2.02%)
مغلق
حجم التداول
68,728
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
178,170,083
العنوان: Cognition Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.